<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08935</article-id><article-id pub-id-type="doi">10.7554/eLife.08935</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Human blindsight is mediated by an intact geniculo-extrastriate pathway</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-35237"><name><surname>Ajina</surname><given-names>Sara</given-names></name><aff><institution content-type="dept">Oxford Centre for Functional MRI of the Brain</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35240"><name><surname>Pestilli</surname><given-names>Franco</given-names></name><aff><institution content-type="dept">Department of Psychological and Brain Sciences, Programs in Neuroscience and Cognitive Science, Indiana University Network Science Institute</institution>, <institution>Indiana University</institution>, <addr-line><named-content content-type="city">Bloomington</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35238"><name><surname>Rokem</surname><given-names>Ariel</given-names></name><aff><institution content-type="dept">Department of Psychology</institution>, <institution>Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35239"><name><surname>Kennard</surname><given-names>Christopher</given-names></name><aff><institution content-type="dept">Nuffield Department of Clinical Neurosciences</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-34475"><name><surname>Bridge</surname><given-names>Holly</given-names></name><aff><institution content-type="dept">Oxford Centre for Functional MRI of the Brain</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country><email>holly.bridge@ndcn.ox.ac.uk</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-6386"><name><surname>Brown</surname><given-names>Emery N</given-names></name><role>Reviewing editor</role><aff><institution>Massachusetts Institute of Technology</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>10</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e08935</elocation-id><supplementary-material><ext-link xlink:href="elife-08935-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>22</day><month>05</month><year>2015</year></date><date date-type="accepted"><day>20</day><month>10</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Ajina et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Ajina et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Although damage to the primary visual cortex (V1) causes hemianopia, many patients retain some residual vision; known as blindsight. We show that blindsight may be facilitated by an intact white-matter pathway between the lateral geniculate nucleus and motion area hMT+. Visual psychophysics, diffusion-weighted magnetic resonance imaging and fibre tractography were applied in 17 patients with V1 damage acquired during adulthood and 9 age-matched controls. Individuals with V1 damage were subdivided into blindsight positive (preserved residual vision) and negative (no residual vision) according to psychophysical performance. All blindsight positive individuals showed intact geniculo-hMT+ pathways, while this pathway was significantly impaired or not measurable in blindsight negative individuals. Two white matter pathways previously implicated in blindsight; (i) superior colliculus to hMT+ and (ii) between hMT+ in each hemisphere were not consistently present in blindsight positive cases. Understanding the visual pathways crucial for residual vision may direct future rehabilitation strategies for hemianopia patients.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Ethical approval was provided by the Oxfordshire Research Ethics Committee B (Ref B08/H0605/156). All participants gave informed, written consent.</p></fn></fn-group></back></article>